The global Complicated Skin and Skin Structure Infections Drugs market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Tedizolid Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Complicated Skin and Skin Structure Infections Drugs include Novartis AG, Endo International Inc, Teva Pharmaceutical Industries Ltd, Glenmark Pharmaceuticals Ltd, Cipla Inc, Dr Reddy's Laboratories Ltd, Abbott, F. Hoffmann-La Roche Ltd and Pfizer Inc, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
Skin and skin structure infections are among the most common bacterial infection of skin-related tissues. The increased antimicrobial resistance among both gram-positive and gram-negative bacteria is a rapidly growing reason for hospitalization in complicated skin structural infections. Skin structural infections are usually considered complicated in case of needed surgery combined with antimicrobial therapy. The complicated skin structural infections generally include burns, ulcers, and major underlying diseases that complicate antibiotic treatment. The major symptoms of skin and skin structure infections include pus, blisters, skin sloughing, breakdown, and skin being discolored and painful.
This report aims to provide a comprehensive presentation of the global market for Complicated Skin and Skin Structure Infections Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Complicated Skin and Skin Structure Infections Drugs. This report contains market size and forecasts of Complicated Skin and Skin Structure Infections Drugs in global, including the following market information:
Global Complicated Skin and Skin Structure Infections Drugs Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global Complicated Skin and Skin Structure Infections Drugs Market Sales, 2019-2024, 2025-2030, (Tons)
Global top five Complicated Skin and Skin Structure Infections Drugs companies in 2023 (%)
We surveyed the Complicated Skin and Skin Structure Infections Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Complicated Skin and Skin Structure Infections Drugs Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (Tons)
Global Complicated Skin and Skin Structure Infections Drugs Market Segment Percentages, by Type, 2023 (%)
Tedizolid
Vancomycin
Ceftaroline
Linezolid
Darbavansing
Olivanstar
Tedizolid
Global Complicated Skin and Skin Structure Infections Drugs Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (Tons)
Global Complicated Skin and Skin Structure Infections Drugs Market Segment Percentages, by Application, 2023 (%)
Hospital
Specialist Clinic
Home Care
Other
Global Complicated Skin and Skin Structure Infections Drugs Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (Tons)
Global Complicated Skin and Skin Structure Infections Drugs Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Complicated Skin and Skin Structure Infections Drugs revenues in global market, 2019-2024 (Estimated), ($ millions)
Key companies Complicated Skin and Skin Structure Infections Drugs revenues share in global market, 2023 (%)
Key companies Complicated Skin and Skin Structure Infections Drugs sales in global market, 2019-2024 (Estimated), (Tons)
Key companies Complicated Skin and Skin Structure Infections Drugs sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis AG
Endo International Inc
Teva Pharmaceutical Industries Ltd
Glenmark Pharmaceuticals Ltd
Cipla Inc
Dr Reddy's Laboratories Ltd
Abbott
F. Hoffmann-La Roche Ltd
Pfizer Inc
Zydus Group
Lupin
Melinta Therapeutics, Inc
MerLion Pharmaceuticals GmbH
Paratek Pharmaceuticals, Inc
Outline of Major Chapters:
Chapter 1: Introduces the definition of Complicated Skin and Skin Structure Infections Drugs, market overview.
Chapter 2: Global Complicated Skin and Skin Structure Infections Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Complicated Skin and Skin Structure Infections Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Complicated Skin and Skin Structure Infections Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Complicated Skin and Skin Structure Infections Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Complicated Skin and Skin Structure Infections Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Complicated Skin and Skin Structure Infections Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Complicated Skin and Skin Structure Infections Drugs Overall Market Size
2.1 Global Complicated Skin and Skin Structure Infections Drugs Market Size: 2023 VS 2030
2.2 Global Complicated Skin and Skin Structure Infections Drugs Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Complicated Skin and Skin Structure Infections Drugs Sales: 2019-2030
3 Company Landscape
3.1 Top Complicated Skin and Skin Structure Infections Drugs Players in Global Market
3.2 Top Global Complicated Skin and Skin Structure Infections Drugs Companies Ranked by Revenue
3.3 Global Complicated Skin and Skin Structure Infections Drugs Revenue by Companies
3.4 Global Complicated Skin and Skin Structure Infections Drugs Sales by Companies
3.5 Global Complicated Skin and Skin Structure Infections Drugs Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Complicated Skin and Skin Structure Infections Drugs Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Complicated Skin and Skin Structure Infections Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Complicated Skin and Skin Structure Infections Drugs Players in Global Market
3.8.1 List of Global Tier 1 Complicated Skin and Skin Structure Infections Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Complicated Skin and Skin Structure Infections Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Complicated Skin and Skin Structure Infections Drugs Market Size Markets, 2023 & 2030
4.1.2 Tedizolid
4.1.3 Vancomycin
4.1.4 Ceftaroline
4.1.5 Linezolid
4.1.6 Darbavansing
4.1.7 Olivanstar
4.1.8 Tedizolid
4.2 By Type - Global Complicated Skin and Skin Structure Infections Drugs Revenue & Forecasts
4.2.1 By Type - Global Complicated Skin and Skin Structure Infections Drugs Revenue, 2019-2024
4.2.2 By Type - Global Complicated Skin and Skin Structure Infections Drugs Revenue, 2025-2030
4.2.3 By Type - Global Complicated Skin and Skin Structure Infections Drugs Revenue Market Share, 2019-2030
4.3 By Type - Global Complicated Skin and Skin Structure Infections Drugs Sales & Forecasts
4.3.1 By Type - Global Complicated Skin and Skin Structure Infections Drugs Sales, 2019-2024
4.3.2 By Type - Global Complicated Skin and Skin Structure Infections Drugs Sales, 2025-2030
4.3.3 By Type - Global Complicated Skin and Skin Structure Infections Drugs Sales Market Share, 2019-2030
4.4 By Type - Global Complicated Skin and Skin Structure Infections Drugs Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Complicated Skin and Skin Structure Infections Drugs Market Size, 2023 & 2030
5.1.2 Hospital
5.1.3 Specialist Clinic
5.1.4 Home Care
5.1.5 Other
5.2 By Application - Global Complicated Skin and Skin Structure Infections Drugs Revenue & Forecasts
5.2.1 By Application - Global Complicated Skin and Skin Structure Infections Drugs Revenue, 2019-2024
5.2.2 By Application - Global Complicated Skin and Skin Structure Infections Drugs Revenue, 2025-2030
5.2.3 By Application - Global Complicated Skin and Skin Structure Infections Drugs Revenue Market Share, 2019-2030
5.3 By Application - Global Complicated Skin and Skin Structure Infections Drugs Sales & Forecasts
5.3.1 By Application - Global Complicated Skin and Skin Structure Infections Drugs Sales, 2019-2024
5.3.2 By Application - Global Complicated Skin and Skin Structure Infections Drugs Sales, 2025-2030
5.3.3 By Application - Global Complicated Skin and Skin Structure Infections Drugs Sales Market Share, 2019-2030
5.4 By Application - Global Complicated Skin and Skin Structure Infections Drugs Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Complicated Skin and Skin Structure Infections Drugs Market Size, 2023 & 2030
6.2 By Region - Global Complicated Skin and Skin Structure Infections Drugs Revenue & Forecasts
6.2.1 By Region - Global Complicated Skin and Skin Structure Infections Drugs Revenue, 2019-2024
6.2.2 By Region - Global Complicated Skin and Skin Structure Infections Drugs Revenue, 2025-2030
6.2.3 By Region - Global Complicated Skin and Skin Structure Infections Drugs Revenue Market Share, 2019-2030
6.3 By Region - Global Complicated Skin and Skin Structure Infections Drugs Sales & Forecasts
6.3.1 By Region - Global Complicated Skin and Skin Structure Infections Drugs Sales, 2019-2024
6.3.2 By Region - Global Complicated Skin and Skin Structure Infections Drugs Sales, 2025-2030
6.3.3 By Region - Global Complicated Skin and Skin Structure Infections Drugs Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Complicated Skin and Skin Structure Infections Drugs Revenue, 2019-2030
6.4.2 By Country - North America Complicated Skin and Skin Structure Infections Drugs Sales, 2019-2030
6.4.3 US Complicated Skin and Skin Structure Infections Drugs Market Size, 2019-2030
6.4.4 Canada Complicated Skin and Skin Structure Infections Drugs Market Size, 2019-2030
6.4.5 Mexico Complicated Skin and Skin Structure Infections Drugs Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Complicated Skin and Skin Structure Infections Drugs Revenue, 2019-2030
6.5.2 By Country - Europe Complicated Skin and Skin Structure Infections Drugs Sales, 2019-2030
6.5.3 Germany Complicated Skin and Skin Structure Infections Drugs Market Size, 2019-2030
6.5.4 France Complicated Skin and Skin Structure Infections Drugs Market Size, 2019-2030
6.5.5 U.K. Complicated Skin and Skin Structure Infections Drugs Market Size, 2019-2030
6.5.6 Italy Complicated Skin and Skin Structure Infections Drugs Market Size, 2019-2030
6.5.7 Russia Complicated Skin and Skin Structure Infections Drugs Market Size, 2019-2030
6.5.8 Nordic Countries Complicated Skin and Skin Structure Infections Drugs Market Size, 2019-2030
6.5.9 Benelux Complicated Skin and Skin Structure Infections Drugs Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Complicated Skin and Skin Structure Infections Drugs Revenue, 2019-2030
6.6.2 By Region - Asia Complicated Skin and Skin Structure Infections Drugs Sales, 2019-2030
6.6.3 China Complicated Skin and Skin Structure Infections Drugs Market Size, 2019-2030
6.6.4 Japan Complicated Skin and Skin Structure Infections Drugs Market Size, 2019-2030
6.6.5 South Korea Complicated Skin and Skin Structure Infections Drugs Market Size, 2019-2030
6.6.6 Southeast Asia Complicated Skin and Skin Structure Infections Drugs Market Size, 2019-2030
6.6.7 India Complicated Skin and Skin Structure Infections Drugs Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Complicated Skin and Skin Structure Infections Drugs Revenue, 2019-2030
6.7.2 By Country - South America Complicated Skin and Skin Structure Infections Drugs Sales, 2019-2030
6.7.3 Brazil Complicated Skin and Skin Structure Infections Drugs Market Size, 2019-2030
6.7.4 Argentina Complicated Skin and Skin Structure Infections Drugs Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Complicated Skin and Skin Structure Infections Drugs Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Complicated Skin and Skin Structure Infections Drugs Sales, 2019-2030
6.8.3 Turkey Complicated Skin and Skin Structure Infections Drugs Market Size, 2019-2030
6.8.4 Israel Complicated Skin and Skin Structure Infections Drugs Market Size, 2019-2030
6.8.5 Saudi Arabia Complicated Skin and Skin Structure Infections Drugs Market Size, 2019-2030
6.8.6 UAE Complicated Skin and Skin Structure Infections Drugs Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 Novartis AG
7.1.1 Novartis AG Company Summary
7.1.2 Novartis AG Business Overview
7.1.3 Novartis AG Complicated Skin and Skin Structure Infections Drugs Major Product Offerings
7.1.4 Novartis AG Complicated Skin and Skin Structure Infections Drugs Sales and Revenue in Global (2019-2024)
7.1.5 Novartis AG Key News & Latest Developments
7.2 Endo International Inc
7.2.1 Endo International Inc Company Summary
7.2.2 Endo International Inc Business Overview
7.2.3 Endo International Inc Complicated Skin and Skin Structure Infections Drugs Major Product Offerings
7.2.4 Endo International Inc Complicated Skin and Skin Structure Infections Drugs Sales and Revenue in Global (2019-2024)
7.2.5 Endo International Inc Key News & Latest Developments
7.3 Teva Pharmaceutical Industries Ltd
7.3.1 Teva Pharmaceutical Industries Ltd Company Summary
7.3.2 Teva Pharmaceutical Industries Ltd Business Overview
7.3.3 Teva Pharmaceutical Industries Ltd Complicated Skin and Skin Structure Infections Drugs Major Product Offerings
7.3.4 Teva Pharmaceutical Industries Ltd Complicated Skin and Skin Structure Infections Drugs Sales and Revenue in Global (2019-2024)
7.3.5 Teva Pharmaceutical Industries Ltd Key News & Latest Developments
7.4 Glenmark Pharmaceuticals Ltd
7.4.1 Glenmark Pharmaceuticals Ltd Company Summary
7.4.2 Glenmark Pharmaceuticals Ltd Business Overview
7.4.3 Glenmark Pharmaceuticals Ltd Complicated Skin and Skin Structure Infections Drugs Major Product Offerings
7.4.4 Glenmark Pharmaceuticals Ltd Complicated Skin and Skin Structure Infections Drugs Sales and Revenue in Global (2019-2024)
7.4.5 Glenmark Pharmaceuticals Ltd Key News & Latest Developments
7.5 Cipla Inc
7.5.1 Cipla Inc Company Summary
7.5.2 Cipla Inc Business Overview
7.5.3 Cipla Inc Complicated Skin and Skin Structure Infections Drugs Major Product Offerings
7.5.4 Cipla Inc Complicated Skin and Skin Structure Infections Drugs Sales and Revenue in Global (2019-2024)
7.5.5 Cipla Inc Key News & Latest Developments
7.6 Dr Reddy's Laboratories Ltd
7.6.1 Dr Reddy's Laboratories Ltd Company Summary
7.6.2 Dr Reddy's Laboratories Ltd Business Overview
7.6.3 Dr Reddy's Laboratories Ltd Complicated Skin and Skin Structure Infections Drugs Major Product Offerings
7.6.4 Dr Reddy's Laboratories Ltd Complicated Skin and Skin Structure Infections Drugs Sales and Revenue in Global (2019-2024)
7.6.5 Dr Reddy's Laboratories Ltd Key News & Latest Developments
7.7 Abbott
7.7.1 Abbott Company Summary
7.7.2 Abbott Business Overview
7.7.3 Abbott Complicated Skin and Skin Structure Infections Drugs Major Product Offerings
7.7.4 Abbott Complicated Skin and Skin Structure Infections Drugs Sales and Revenue in Global (2019-2024)
7.7.5 Abbott Key News & Latest Developments
7.8 F. Hoffmann-La Roche Ltd
7.8.1 F. Hoffmann-La Roche Ltd Company Summary
7.8.2 F. Hoffmann-La Roche Ltd Business Overview
7.8.3 F. Hoffmann-La Roche Ltd Complicated Skin and Skin Structure Infections Drugs Major Product Offerings
7.8.4 F. Hoffmann-La Roche Ltd Complicated Skin and Skin Structure Infections Drugs Sales and Revenue in Global (2019-2024)
7.8.5 F. Hoffmann-La Roche Ltd Key News & Latest Developments
7.9 Pfizer Inc
7.9.1 Pfizer Inc Company Summary
7.9.2 Pfizer Inc Business Overview
7.9.3 Pfizer Inc Complicated Skin and Skin Structure Infections Drugs Major Product Offerings
7.9.4 Pfizer Inc Complicated Skin and Skin Structure Infections Drugs Sales and Revenue in Global (2019-2024)
7.9.5 Pfizer Inc Key News & Latest Developments
7.10 Zydus Group
7.10.1 Zydus Group Company Summary
7.10.2 Zydus Group Business Overview
7.10.3 Zydus Group Complicated Skin and Skin Structure Infections Drugs Major Product Offerings
7.10.4 Zydus Group Complicated Skin and Skin Structure Infections Drugs Sales and Revenue in Global (2019-2024)
7.10.5 Zydus Group Key News & Latest Developments
7.11 Lupin
7.11.1 Lupin Company Summary
7.11.2 Lupin Complicated Skin and Skin Structure Infections Drugs Business Overview
7.11.3 Lupin Complicated Skin and Skin Structure Infections Drugs Major Product Offerings
7.11.4 Lupin Complicated Skin and Skin Structure Infections Drugs Sales and Revenue in Global (2019-2024)
7.11.5 Lupin Key News & Latest Developments
7.12 Melinta Therapeutics, Inc
7.12.1 Melinta Therapeutics, Inc Company Summary
7.12.2 Melinta Therapeutics, Inc Complicated Skin and Skin Structure Infections Drugs Business Overview
7.12.3 Melinta Therapeutics, Inc Complicated Skin and Skin Structure Infections Drugs Major Product Offerings
7.12.4 Melinta Therapeutics, Inc Complicated Skin and Skin Structure Infections Drugs Sales and Revenue in Global (2019-2024)
7.12.5 Melinta Therapeutics, Inc Key News & Latest Developments
7.13 MerLion Pharmaceuticals GmbH
7.13.1 MerLion Pharmaceuticals GmbH Company Summary
7.13.2 MerLion Pharmaceuticals GmbH Complicated Skin and Skin Structure Infections Drugs Business Overview
7.13.3 MerLion Pharmaceuticals GmbH Complicated Skin and Skin Structure Infections Drugs Major Product Offerings
7.13.4 MerLion Pharmaceuticals GmbH Complicated Skin and Skin Structure Infections Drugs Sales and Revenue in Global (2019-2024)
7.13.5 MerLion Pharmaceuticals GmbH Key News & Latest Developments
7.14 Paratek Pharmaceuticals, Inc
7.14.1 Paratek Pharmaceuticals, Inc Company Summary
7.14.2 Paratek Pharmaceuticals, Inc Business Overview
7.14.3 Paratek Pharmaceuticals, Inc Complicated Skin and Skin Structure Infections Drugs Major Product Offerings
7.14.4 Paratek Pharmaceuticals, Inc Complicated Skin and Skin Structure Infections Drugs Sales and Revenue in Global (2019-2024)
7.14.5 Paratek Pharmaceuticals, Inc Key News & Latest Developments
8 Global Complicated Skin and Skin Structure Infections Drugs Production Capacity, Analysis
8.1 Global Complicated Skin and Skin Structure Infections Drugs Production Capacity, 2019-2030
8.2 Complicated Skin and Skin Structure Infections Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Complicated Skin and Skin Structure Infections Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Complicated Skin and Skin Structure Infections Drugs Supply Chain Analysis
10.1 Complicated Skin and Skin Structure Infections Drugs Industry Value Chain
10.2 Complicated Skin and Skin Structure Infections Drugs Upstream Market
10.3 Complicated Skin and Skin Structure Infections Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Complicated Skin and Skin Structure Infections Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Complicated Skin and Skin Structure Infections Drugs in Global Market
Table 2. Top Complicated Skin and Skin Structure Infections Drugs Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Complicated Skin and Skin Structure Infections Drugs Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Complicated Skin and Skin Structure Infections Drugs Revenue Share by Companies, 2019-2024
Table 5. Global Complicated Skin and Skin Structure Infections Drugs Sales by Companies, (Tons), 2019-2024
Table 6. Global Complicated Skin and Skin Structure Infections Drugs Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Complicated Skin and Skin Structure Infections Drugs Price (2019-2024) & (US$/Ton)
Table 8. Global Manufacturers Complicated Skin and Skin Structure Infections Drugs Product Type
Table 9. List of Global Tier 1 Complicated Skin and Skin Structure Infections Drugs Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Complicated Skin and Skin Structure Infections Drugs Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Complicated Skin and Skin Structure Infections Drugs Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Complicated Skin and Skin Structure Infections Drugs Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Complicated Skin and Skin Structure Infections Drugs Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Complicated Skin and Skin Structure Infections Drugs Sales (Tons), 2019-2024
Table 15. By Type - Global Complicated Skin and Skin Structure Infections Drugs Sales (Tons), 2025-2030
Table 16. By Application ? Global Complicated Skin and Skin Structure Infections Drugs Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Complicated Skin and Skin Structure Infections Drugs Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Complicated Skin and Skin Structure Infections Drugs Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Complicated Skin and Skin Structure Infections Drugs Sales (Tons), 2019-2024
Table 20. By Application - Global Complicated Skin and Skin Structure Infections Drugs Sales (Tons), 2025-2030
Table 21. By Region ? Global Complicated Skin and Skin Structure Infections Drugs Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Complicated Skin and Skin Structure Infections Drugs Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Complicated Skin and Skin Structure Infections Drugs Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Complicated Skin and Skin Structure Infections Drugs Sales (Tons), 2019-2024
Table 25. By Region - Global Complicated Skin and Skin Structure Infections Drugs Sales (Tons), 2025-2030
Table 26. By Country - North America Complicated Skin and Skin Structure Infections Drugs Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Complicated Skin and Skin Structure Infections Drugs Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Complicated Skin and Skin Structure Infections Drugs Sales, (Tons), 2019-2024
Table 29. By Country - North America Complicated Skin and Skin Structure Infections Drugs Sales, (Tons), 2025-2030
Table 30. By Country - Europe Complicated Skin and Skin Structure Infections Drugs Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Complicated Skin and Skin Structure Infections Drugs Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Complicated Skin and Skin Structure Infections Drugs Sales, (Tons), 2019-2024
Table 33. By Country - Europe Complicated Skin and Skin Structure Infections Drugs Sales, (Tons), 2025-2030
Table 34. By Region - Asia Complicated Skin and Skin Structure Infections Drugs Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Complicated Skin and Skin Structure Infections Drugs Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Complicated Skin and Skin Structure Infections Drugs Sales, (Tons), 2019-2024
Table 37. By Region - Asia Complicated Skin and Skin Structure Infections Drugs Sales, (Tons), 2025-2030
Table 38. By Country - South America Complicated Skin and Skin Structure Infections Drugs Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Complicated Skin and Skin Structure Infections Drugs Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Complicated Skin and Skin Structure Infections Drugs Sales, (Tons), 2019-2024
Table 41. By Country - South America Complicated Skin and Skin Structure Infections Drugs Sales, (Tons), 2025-2030
Table 42. By Country - Middle East & Africa Complicated Skin and Skin Structure Infections Drugs Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Complicated Skin and Skin Structure Infections Drugs Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Complicated Skin and Skin Structure Infections Drugs Sales, (Tons), 2019-2024
Table 45. By Country - Middle East & Africa Complicated Skin and Skin Structure Infections Drugs Sales, (Tons), 2025-2030
Table 46. Novartis AG Company Summary
Table 47. Novartis AG Complicated Skin and Skin Structure Infections Drugs Product Offerings
Table 48. Novartis AG Complicated Skin and Skin Structure Infections Drugs Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2019-2024)
Table 49. Novartis AG Key News & Latest Developments
Table 50. Endo International Inc Company Summary
Table 51. Endo International Inc Complicated Skin and Skin Structure Infections Drugs Product Offerings
Table 52. Endo International Inc Complicated Skin and Skin Structure Infections Drugs Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2019-2024)
Table 53. Endo International Inc Key News & Latest Developments
Table 54. Teva Pharmaceutical Industries Ltd Company Summary
Table 55. Teva Pharmaceutical Industries Ltd Complicated Skin and Skin Structure Infections Drugs Product Offerings
Table 56. Teva Pharmaceutical Industries Ltd Complicated Skin and Skin Structure Infections Drugs Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2019-2024)
Table 57. Teva Pharmaceutical Industries Ltd Key News & Latest Developments
Table 58. Glenmark Pharmaceuticals Ltd Company Summary
Table 59. Glenmark Pharmaceuticals Ltd Complicated Skin and Skin Structure Infections Drugs Product Offerings
Table 60. Glenmark Pharmaceuticals Ltd Complicated Skin and Skin Structure Infections Drugs Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2019-2024)
Table 61. Glenmark Pharmaceuticals Ltd Key News & Latest Developments
Table 62. Cipla Inc Company Summary
Table 63. Cipla Inc Complicated Skin and Skin Structure Infections Drugs Product Offerings
Table 64. Cipla Inc Complicated Skin and Skin Structure Infections Drugs Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2019-2024)
Table 65. Cipla Inc Key News & Latest Developments
Table 66. Dr Reddy's Laboratories Ltd Company Summary
Table 67. Dr Reddy's Laboratories Ltd Complicated Skin and Skin Structure Infections Drugs Product Offerings
Table 68. Dr Reddy's Laboratories Ltd Complicated Skin and Skin Structure Infections Drugs Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2019-2024)
Table 69. Dr Reddy's Laboratories Ltd Key News & Latest Developments
Table 70. Abbott Company Summary
Table 71. Abbott Complicated Skin and Skin Structure Infections Drugs Product Offerings
Table 72. Abbott Complicated Skin and Skin Structure Infections Drugs Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2019-2024)
Table 73. Abbott Key News & Latest Developments
Table 74. F. Hoffmann-La Roche Ltd Company Summary
Table 75. F. Hoffmann-La Roche Ltd Complicated Skin and Skin Structure Infections Drugs Product Offerings
Table 76. F. Hoffmann-La Roche Ltd Complicated Skin and Skin Structure Infections Drugs Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2019-2024)
Table 77. F. Hoffmann-La Roche Ltd Key News & Latest Developments
Table 78. Pfizer Inc Company Summary
Table 79. Pfizer Inc Complicated Skin and Skin Structure Infections Drugs Product Offerings
Table 80. Pfizer Inc Complicated Skin and Skin Structure Infections Drugs Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2019-2024)
Table 81. Pfizer Inc Key News & Latest Developments
Table 82. Zydus Group Company Summary
Table 83. Zydus Group Complicated Skin and Skin Structure Infections Drugs Product Offerings
Table 84. Zydus Group Complicated Skin and Skin Structure Infections Drugs Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2019-2024)
Table 85. Zydus Group Key News & Latest Developments
Table 86. Lupin Company Summary
Table 87. Lupin Complicated Skin and Skin Structure Infections Drugs Product Offerings
Table 88. Lupin Complicated Skin and Skin Structure Infections Drugs Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2019-2024)
Table 89. Lupin Key News & Latest Developments
Table 90. Melinta Therapeutics, Inc Company Summary
Table 91. Melinta Therapeutics, Inc Complicated Skin and Skin Structure Infections Drugs Product Offerings
Table 92. Melinta Therapeutics, Inc Complicated Skin and Skin Structure Infections Drugs Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2019-2024)
Table 93. Melinta Therapeutics, Inc Key News & Latest Developments
Table 94. MerLion Pharmaceuticals GmbH Company Summary
Table 95. MerLion Pharmaceuticals GmbH Complicated Skin and Skin Structure Infections Drugs Product Offerings
Table 96. MerLion Pharmaceuticals GmbH Complicated Skin and Skin Structure Infections Drugs Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2019-2024)
Table 97. MerLion Pharmaceuticals GmbH Key News & Latest Developments
Table 98. Paratek Pharmaceuticals, Inc Company Summary
Table 99. Paratek Pharmaceuticals, Inc Complicated Skin and Skin Structure Infections Drugs Product Offerings
Table 100. Paratek Pharmaceuticals, Inc Complicated Skin and Skin Structure Infections Drugs Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2019-2024)
Table 101. Paratek Pharmaceuticals, Inc Key News & Latest Developments
Table 102. Complicated Skin and Skin Structure Infections Drugs Production Capacity (Tons) of Key Manufacturers in Global Market, 2021-2024 (Tons)
Table 103. Global Complicated Skin and Skin Structure Infections Drugs Capacity Market Share of Key Manufacturers, 2021-2024
Table 104. Global Complicated Skin and Skin Structure Infections Drugs Production by Region, 2019-2024 (Tons)
Table 105. Global Complicated Skin and Skin Structure Infections Drugs Production by Region, 2025-2030 (Tons)
Table 106. Complicated Skin and Skin Structure Infections Drugs Market Opportunities & Trends in Global Market
Table 107. Complicated Skin and Skin Structure Infections Drugs Market Drivers in Global Market
Table 108. Complicated Skin and Skin Structure Infections Drugs Market Restraints in Global Market
Table 109. Complicated Skin and Skin Structure Infections Drugs Raw Materials
Table 110. Complicated Skin and Skin Structure Infections Drugs Raw Materials Suppliers in Global Market
Table 111. Typical Complicated Skin and Skin Structure Infections Drugs Downstream
Table 112. Complicated Skin and Skin Structure Infections Drugs Downstream Clients in Global Market
Table 113. Complicated Skin and Skin Structure Infections Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Complicated Skin and Skin Structure Infections Drugs Segment by Type in 2023
Figure 2. Complicated Skin and Skin Structure Infections Drugs Segment by Application in 2023
Figure 3. Global Complicated Skin and Skin Structure Infections Drugs Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Complicated Skin and Skin Structure Infections Drugs Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Complicated Skin and Skin Structure Infections Drugs Revenue, 2019-2030 (US$, Mn)
Figure 7. Complicated Skin and Skin Structure Infections Drugs Sales in Global Market: 2019-2030 (Tons)
Figure 8. The Top 3 and 5 Players Market Share by Complicated Skin and Skin Structure Infections Drugs Revenue in 2023
Figure 9. By Type - Global Complicated Skin and Skin Structure Infections Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Complicated Skin and Skin Structure Infections Drugs Revenue Market Share, 2019-2030
Figure 11. By Type - Global Complicated Skin and Skin Structure Infections Drugs Sales Market Share, 2019-2030
Figure 12. By Type - Global Complicated Skin and Skin Structure Infections Drugs Price (US$/Ton), 2019-2030
Figure 13. By Application - Global Complicated Skin and Skin Structure Infections Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Complicated Skin and Skin Structure Infections Drugs Revenue Market Share, 2019-2030
Figure 15. By Application - Global Complicated Skin and Skin Structure Infections Drugs Sales Market Share, 2019-2030
Figure 16. By Application - Global Complicated Skin and Skin Structure Infections Drugs Price (US$/Ton), 2019-2030
Figure 17. By Region - Global Complicated Skin and Skin Structure Infections Drugs Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Complicated Skin and Skin Structure Infections Drugs Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Complicated Skin and Skin Structure Infections Drugs Revenue Market Share, 2019-2030
Figure 20. By Region - Global Complicated Skin and Skin Structure Infections Drugs Sales Market Share, 2019-2030
Figure 21. By Country - North America Complicated Skin and Skin Structure Infections Drugs Revenue Market Share, 2019-2030
Figure 22. By Country - North America Complicated Skin and Skin Structure Infections Drugs Sales Market Share, 2019-2030
Figure 23. US Complicated Skin and Skin Structure Infections Drugs Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Complicated Skin and Skin Structure Infections Drugs Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Complicated Skin and Skin Structure Infections Drugs Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Complicated Skin and Skin Structure Infections Drugs Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Complicated Skin and Skin Structure Infections Drugs Sales Market Share, 2019-2030
Figure 28. Germany Complicated Skin and Skin Structure Infections Drugs Revenue, (US$, Mn), 2019-2030
Figure 29. France Complicated Skin and Skin Structure Infections Drugs Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Complicated Skin and Skin Structure Infections Drugs Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Complicated Skin and Skin Structure Infections Drugs Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Complicated Skin and Skin Structure Infections Drugs Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Complicated Skin and Skin Structure Infections Drugs Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Complicated Skin and Skin Structure Infections Drugs Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Complicated Skin and Skin Structure Infections Drugs Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Complicated Skin and Skin Structure Infections Drugs Sales Market Share, 2019-2030
Figure 37. China Complicated Skin and Skin Structure Infections Drugs Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Complicated Skin and Skin Structure Infections Drugs Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Complicated Skin and Skin Structure Infections Drugs Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Complicated Skin and Skin Structure Infections Drugs Revenue, (US$, Mn), 2019-2030
Figure 41. India Complicated Skin and Skin Structure Infections Drugs Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Complicated Skin and Skin Structure Infections Drugs Revenue Market Share, 2019-2030
Figure 43. By Country - South America Complicated Skin and Skin Structure Infections Drugs Sales Market Share, 2019-2030
Figure 44. Brazil Complicated Skin and Skin Structure Infections Drugs Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Complicated Skin and Skin Structure Infections Drugs Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Complicated Skin and Skin Structure Infections Drugs Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Complicated Skin and Skin Structure Infections Drugs Sales Market Share, 2019-2030
Figure 48. Turkey Complicated Skin and Skin Structure Infections Drugs Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Complicated Skin and Skin Structure Infections Drugs Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Complicated Skin and Skin Structure Infections Drugs Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Complicated Skin and Skin Structure Infections Drugs Revenue, (US$, Mn), 2019-2030
Figure 52. Global Complicated Skin and Skin Structure Infections Drugs Production Capacity (Tons), 2019-2030
Figure 53. The Percentage of Production Complicated Skin and Skin Structure Infections Drugs by Region, 2023 VS 2030
Figure 54. Complicated Skin and Skin Structure Infections Drugs Industry Value Chain
Figure 55. Marketing Channels
